[1]
S, R.K. et al. 2019. A RANDOMIZED CLINICAL ENDPOINT STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CLEARLIV TABLETS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE. Asian Journal of Pharmaceutical and Clinical Research. 12, 1 (Jan. 2019), 297–300. DOI:https://doi.org/10.22159/ajpcr.2019.v12i1.29921.